Global Hospital Acquired Urinary Tract Infection Market, By Clinical Indications (Cystitis, Urethritis, and Pyelonephritis), By Drug Class (Aminoglycosides, Quinolones, ?-lactam, and Azoles), By End Users (Hospitals & Intensive Care Units (ICUs), Ambulatory Surgical & Diagnostic Centers, and Nursing Homes & Maternity Centers), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2029

Prophecy Market Insights has recently published its insights on “Global Hospital Acquired Urinary Tract Infection Market” for the forecast period of 2018-2029. The market is segmented into By Clinical Indications (Cystitis, Urethritis, and Pyelonephritis), By Drug Class (Aminoglycosides, Quinolones, β-lactam, and Azoles), By End Users (Hospitals & Intensive Care Units (ICUs), Ambulatory Surgical & Diagnostic Centers, and Nursing Homes & Maternity Centers), and By Region.

This market is expected to witness significant growth during the forecast period on account of increase in prevalence of hospital acquired UTIs across the globe. In addition, increase in the government investment for the development of healthcare sector especially in emerging countries is propelling growth of the global market. Furthermore, increasing awareness about the infections in hospitals staff members is the boosting the target market growth.

North America to grow at the highest CAGR during the forecast period

North America is dominating the target market followed by Europe owing to the proper utilization of sterile catheters and hygienic hospital conditions. In addition, favorable government investments for healthcare industries have boosted the target market growth in Europe. Asia-Pacific is anticipated to show a significant growth in the global market during forecast period owing to the increasing awareness about the infections in hospitals staff members. In addition, increase in the government investment for the development of healthcare sector is boosting the global market growth in the region.

The research scope provides comprehensive market size, and other in-depth market information details such as, market growth supporting factors, restraining factors, trends, opportunities, market risk factors, market competition, product and services advancements and launches, product/services related regulations overview, and recent developments for the mentioned forecast period. In addition, the report provides key examination of market players operating in the specific market and analysis and outcomes related with the target market for more than 20 countries.

In the current research scope 2018 is considered as base year and 2019 is estimated year for market value/volume calculations. The report offers market estimates for the forecast period – 2019 to 2029. The report provides factual inputs and analysis based on primary and secondary research, which includes insights gained through in-depth interviews with primary research participants. Also, the data is gathered from authentic secondary sources and is verified by key opinion leaders in the target market. The in-house research is applied on gathered information to provide more accurate data points and reduce the margin of error. The in-house research and analysis efforts include various tools and 360^o data analysis methodology.

The global hospital acquired urinary tract infection market report segments the market on the basis of clinical indications, drug class, end users, and region.

The report expected to answer various target market related questions and offers insights on:

• Definition, description, overview of market growth influencing factors, and forecast for the target market
• Scope for related market in the forecast period
• Analysis and outcome for the global hospital acquired urinary tract infection market by segment and region followed by countries
• Market segmentation, dominating segment and region followed by country along with market value, share, Y-o-Y growth, CAGR, forecast, and contribution in the market
• Key market player profiles, their recent developments, strategies, financial details, key competencies, presence by region, and product portfolio
• Valuable insights, data, and forecast that can be referenced to plan business strategies, to tap market opportunities, understand business related risks, derive business goals, to recognize trends, and understand target customers/end users
• Insights on recent technologies, pipeline products, regulations related with target market, market investment, and offers insights on political and economical factors that may influence market growth
• PEST Analysis, PORTER’s five forces analysis, opportunity map analysis, drivers and restraints impact analysis, and market attractiveness index

Competitive Analysis

Advancements in the product as well as in manufacturing process, product launches, and strategic partnerships are some trends witnessed in the global hospital acquired urinary tract infection market. For instance, in April 2019, Fortive Corporation announced completion of its acquisition with Advanced Sterilization Products business from Ethicon, Inc., a subsidiary of Johnson & Johnson, for approximately US$2.7 Bn in cash. Advanced Sterilization Products is a leading global provider of innovative disinfection and sterilization solution.

• Advanced Sterilization Products Services, Inc.
• Becton Dickinson & Company
• Steris Corporation
• Getinge Group AB
• Kimberly-Clark Corporation
• Cantel Medical Corporation
• BioMerieux, Inc.
• Belimed AG
• 3M Company PAC
• Sterigenics International LLC

Prophecy Market Insights offers required customization on this report according to specific business requirements.